CytRx Corporation Share Price Nasdaq
Equities
US2328285091
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 644K 53.72M |
---|---|---|---|---|---|
Net income 2022 | -4M -334M | Net income 2023 | - 0 | EV / Sales 2022 | - |
Net cash position 2022 | 1.15M 95.59M | Net cash position 2023 | 2.04M 170M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.05
x | P/E ratio 2023 |
1.91
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.44% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Snowdy
CEO | Chief Executive Officer | 55 | 10/22/10 |
John Caloz
DFI | Director of Finance/CFO | 72 | 01/07/01 |
Cristina Newman
SEC | Corporate Secretary | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jennifer Simpson
CHM | Chairman | 55 | 29/21/29 |
Cary Claiborne
BRD | Director/Board Member | 64 | 27/22/27 |
Joel Caldwell
BRD | Director/Board Member | 69 | 12/17/12 |
1st Jan change | Capi. | |
---|---|---|
+21.95% | 47.9B | |
+46.56% | 41.42B | |
-2.58% | 40.7B | |
-6.20% | 28.92B | |
+10.81% | 25.55B | |
-21.66% | 19.27B | |
-1.50% | 12.15B | |
+30.61% | 12.14B | |
-0.78% | 11.99B |